{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:38:16Z","timestamp":1788910696412,"version":"build-2803163510"},"reference-count":242,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.phrs.2018.07.004","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T19:16:19Z","timestamp":1530990979000},"page":"37-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?"],"prefix":"10.1016","volume":"135","author":[{"given":"Samira","family":"Shirooie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Fazel","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad R.","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun","family":"Belwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Habtemariam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Arg\u00fcelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-6838","authenticated-orcid":false,"given":"Antoni","family":"Sureda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Daglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-1048","authenticated-orcid":false,"given":"Micha\u0142","family":"Tomczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sobarzo-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-5217","authenticated-orcid":false,"given":"Suowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.07.004_bib0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmolb.2015.00054","article-title":"Molecular diagnostics of neurodegenerative disorders","volume":"2","author":"Agrawal","year":"2015","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(16)32381-9","article-title":"Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble","volume":"389","author":"Kontis","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2018.07.004_bib0015","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1007\/s00018-012-1201-4","article-title":"Membrane trafficking in neuronal maintenance and degeneration","volume":"70","author":"Wang","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0020","series-title":"AMP-Activated Protein Kinase","first-page":"153","article-title":"AMPK in neurodegenerative diseases","author":"Domise","year":"2016"},{"key":"10.1016\/j.phrs.2018.07.004_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000329999","article-title":"Role of p53 in neurodegenerative diseases","volume":"9","author":"Chang","year":"2012","journal-title":"Neuro-Degenerative Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2012\/649079","article-title":"The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease","volume":"2012","author":"Corr\u00eaa","year":"2012","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.phrs.2018.07.004_bib0035","doi-asserted-by":"crossref","DOI":"10.4161\/jkst.22925","article-title":"The role of JAK-STAT signaling within the CNS","volume":"2","author":"Nicolas","year":"2013","journal-title":"JAK-STAT"},{"key":"10.1016\/j.phrs.2018.07.004_bib0040","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.3892\/mmr.2016.5586","article-title":"Neuroprotective effects of caffeic acid phenethyl ester against sevoflurane\u2011induced neuronal degeneration in the hippocampus of neonatal rats involve MAPK and PI3K\/Akt signaling pathways","volume":"14","author":"Wang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2018.07.004_bib0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3892\/mmr.2013.1628","article-title":"Neuroprotective effect of brain-derived neurotrophic factor mediated by autophagy through the PI3K\/Akt\/mTOR pathway","volume":"8","author":"Chen","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2018.07.004_bib0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2018.07.004_bib0055","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008771","article-title":"mTOR-dependent cell survival mechanisms","volume":"4","author":"Hung","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0060","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1172\/JCI64099","article-title":"Rapalogs and mTOR inhibitors as anti-aging therapeutics","volume":"123","author":"Lamming","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.07.004_bib0065","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.2174\/092986711795328355","article-title":"Hybrid molecules incorporating natural products: applications in cancer therapy, neurodegenerative disorders and beyond","volume":"18","author":"Decker","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12640-016-9600-1","article-title":"Impact of plant-derived flavonoids on neurodegenerative diseases","volume":"30","author":"Costa","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2006.06.025","article-title":"Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets","volume":"545","author":"Ramassamy","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0080","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.plefa.2007.10.019","article-title":"Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies","volume":"77","author":"Calon","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.phrs.2018.07.004_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"Scorletti","year":"2013","journal-title":"Ann. Rev. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib0090","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1096\/fasebj.5.8.1673664","article-title":"Dietary n-3 (omega-3) polyunsaturated fatty acid effects on animal tumorigenesis","volume":"5","author":"Cave","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2018.07.004_bib0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/157339907781368968","article-title":"Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA","volume":"3","author":"Doughman","year":"2007","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.phrs.2018.07.004_bib0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1475-2859-11-96","article-title":"Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production","volume":"11","author":"Adarme-Vega","year":"2012","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.phrs.2018.07.004_bib0105","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.euroneuro.2012.08.003","article-title":"Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Mozaffari-Khosravi","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0110","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00048670701827275","article-title":"Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder","volume":"42","author":"Jazayeri","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.phrs.2018.07.004_bib0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.atherosclerosis.2006.06.008","article-title":"Age-and dose-dependent effects of an eicosapentaenoic acid-rich oil on cardiovascular risk factors in healthy male subjects","volume":"193","author":"Cazzola","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2018.07.004_bib0120","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1017\/S0007114511006921","article-title":"Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: role of adiponectin and nitric oxide","volume":"108","author":"Lozovoy","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib0125","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","article-title":"Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2018.07.004_bib0130","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00134-008-1142-4","article-title":"Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective","volume":"34","author":"Singer","year":"2008","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1753-4887.2010.00287.x","article-title":"Fatty acids from fish: the anti\u2010inflammatory potential of long-chain omega-3 fatty acids","volume":"68","author":"Wall","year":"2010","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.phrs.2018.07.004_bib0140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","article-title":"Omega-3 fatty acids in inflammation and autoimmune diseases","volume":"21","author":"Simopoulos","year":"2002","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clnu.2015.04.004","article-title":"A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease","volume":"35","author":"Mas","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib0150","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/ajcn\/78.6.1128","article-title":"Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study","volume":"78","author":"Stene","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib0155","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1177\/1352458515604380","article-title":"Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: results from the ausimmune study","volume":"22","author":"Hoare","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.phrs.2018.07.004_bib0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.rbr.2013.12.002","article-title":"Polyunsaturated omega-3 fatty acids and systemic lupus erythematosus: what do we know?","volume":"54","author":"Borges","year":"2014","journal-title":"Rev. Bras. Reumatol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/CCID.S17220","article-title":"Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis","volume":"4","author":"Balb\u00e1s","year":"2011","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/acr.23245","article-title":"Dietary intake of polyunsaturated fatty acids and pain in spite of inflammatory control among methotrexate treated early rheumatoid arthritis patients","volume":"70","author":"Lourdudoss","year":"2017","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12944-017-0586-3","article-title":"Polyunsaturated fatty acids: any role in rheumatoid arthritis?","volume":"16","author":"Navarini","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0180","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw078","article-title":"n-3 polyunsaturated fatty acids through the lifespan: implication for psychopathology","volume":"19","author":"Pusceddu","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15430\/JCP.2017.22.1.1","article-title":"Anti-cancer mechanism of docosahexaenoic acid in pancreatic carcinogenesis: a mini-review","volume":"22","author":"Park","year":"2017","journal-title":"J. Cancer Prevent."},{"key":"10.1016\/j.phrs.2018.07.004_bib0190","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/aje\/kwm063","article-title":"Dietary fatty acids and colorectal cancer: a case-control study","volume":"166","author":"Theodoratou","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13058-015-0571-6","article-title":"Omega-3 fatty acids for breast cancer prevention and survivorship","volume":"17","author":"Fabian","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0200","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nm1591","article-title":"Increased dietary intake of \u03c9-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis","volume":"13","author":"Connor","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0205","article-title":"Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus","volume":"2008","author":"Hartweg","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2018.07.004_bib0210","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/748361","article-title":"Retina and omega-3","volume":"2011","author":"Querques","year":"2011","journal-title":"J. Nutr. Metab."},{"key":"10.1016\/j.phrs.2018.07.004_bib0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1358\/dnp.2009.22.4.1367709","article-title":"Fatty acid facts, part IV: docosahexaenoic acid and Alzheimer\u2019s disease. A story of mice, men and fish","volume":"22","author":"Pauwels","year":"2009","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.phrs.2018.07.004_bib0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1750-3639.2005.tb00513.x","article-title":"Neuroprotectin D1 (NPD1): a DHA\u2010derived mediator that protects brain and retina against cell injury\u2010induced oxidative stress","volume":"15","author":"Bazan","year":"2005","journal-title":"Brain Pathol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0225","doi-asserted-by":"crossref","first-page":"76944","DOI":"10.18632\/oncotarget.12759","article-title":"Elevation of n-3\/n-6 PUFAs ratio suppresses mTORC1 and prevents colorectal carcinogenesis associated with APC mutation","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2018.07.004_bib0230","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3574012","article-title":"Plants-derived neuroprotective agents: cutting the cycle of cell death through multiple mechanisms","volume":"2017","author":"Elufioye","year":"2017","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0235","series-title":"(Society) AAs","year":"2017"},{"key":"10.1016\/j.phrs.2018.07.004_bib0240","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.2174\/1871527313666140917095514","article-title":"Protein misfolding and aggregation in Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"13","author":"Ashraf","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.phrs.2018.07.004_bib0245","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/ijms17111785","article-title":"The impact of vitamin E and other fat-soluble vitamins on Alzheimer\u00b4s disease","volume":"17","author":"Grimm","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0250","first-page":"269","article-title":"Metabolic processing of the amyloid precursor protein\u2014new pieces of the Alzheimer\u2019s puzzle","volume":"23","author":"Norstrom","year":"2017","journal-title":"Discov. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0255","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0260","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/604658","article-title":"The role of oxidative stress-induced epigenetic alterations in amyloid-\u03b2 production in Alzheimer\u2019s disease","volume":"2015","author":"Zuo","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2018.07.004_bib0265","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-170543","article-title":"Oxidative stress, amyloid-\u03b2 peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer\u2019s disease","volume":"62","author":"Butterfield","year":"2018","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0270","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1089\/ars.2016.6802","article-title":"The proteasome and oxidative stress in Alzheimer\u2019s disease","volume":"25","author":"Bonet-Costa","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2018.07.004_bib0275","first-page":"427","article-title":"Interactions between \u03b2-amyloid and central cholinergic neurons: implications for Alzheimer\u2019s disease","volume":"29","author":"Kar","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0280","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","article-title":"Cholinergic system during the progression of Alzheimer\u2019s disease: therapeutic implications","volume":"8","author":"Mufson","year":"2008","journal-title":"Exp. Rev. Neurother."},{"key":"10.1016\/j.phrs.2018.07.004_bib0285","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1179\/1476830511Y.0000000033","article-title":"Cellular and molecular mechanisms of antioxidants in Parkinson\u2019s disease","volume":"15","author":"Sutachan","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0290","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1196\/annals.1332.015","article-title":"The degeneration of dopamine neurons in Parkinson\u2019s disease: insights from embryology and evolution of the mesostriatocortical system","volume":"1035","author":"Vernier","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0295","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0300","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/brain\/124.7.1461","article-title":"Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations","volume":"124","author":"Jacobsson","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2018.07.004_bib0305","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/brain\/awt097","article-title":"Is SOD1 loss of function involved in amyotrophic lateral sclerosis?","volume":"136","author":"Saccon","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2018.07.004_bib0310","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2353\/ajpath.2008.070442","article-title":"Prion diseases: from protein to cell pathology","volume":"172","author":"Kovacs","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0315","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1021\/bi900108v","article-title":"Prion diseases and their biochemical mechanisms","volume":"48","author":"Cobb","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2018.07.004_bib0320","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/JHD-160228","article-title":"Survey of the Huntington\u2019s disease patient and caregiver community reveals most impactful symptoms and treatment needs","volume":"5","author":"Simpson","year":"2016","journal-title":"J. Huntington\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0325","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington\u2019s disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0330","first-page":"69","article-title":"Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis","volume":"7","author":"Santos","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"issue":"26","key":"10.1016\/j.phrs.2018.07.004_bib0335","article-title":"Targeting new candidate genes by small molecules approaching neurodegenerative diseases","volume":"17","author":"Fan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0340","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"P\u00f3pulo","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0345","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.phrs.2018.07.004_bib0350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI73939","article-title":"mTOR: a pharmacologic target for autophagy regulation","volume":"125","author":"Kim","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.07.004_bib0355","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2018.07.004_bib0360","first-page":"5360","article-title":"Regulation of peptide\u2010chain elongation in mammalian cells","volume":"269","author":"Browne","year":"2002","journal-title":"FEBS J."},{"key":"10.1016\/j.phrs.2018.07.004_bib0365","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.2174\/1381612823666170714143426","article-title":"Application of kinase inhibitors for anti-aging intervention","volume":"23","author":"Cano","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2018.07.004_bib0370","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/MCB.21.3.952-965.2001","article-title":"Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a)","volume":"21","author":"Brunet","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0375","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2018.07.004_bib0380","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.cdd.4401751","article-title":"Autophagy and signaling: their role in cell survival and cell death","volume":"12","author":"Codogno","year":"2005","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.phrs.2018.07.004_bib0385","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4161\/cc.10.14.16586","article-title":"mTOR complex 2 signaling and functions","volume":"10","author":"Oh","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.phrs.2018.07.004_bib0390","doi-asserted-by":"crossref","first-page":"12297","DOI":"10.1074\/jbc.M900573200","article-title":"ULK1\u00b7 ATG13\u00b7 FIP200 complex mediates mTOR signaling and is essential for autophagy","volume":"284","author":"Ganley","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0395","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4161\/auto.5.7.9296","article-title":"Atg101, a novel mammalian autophagy protein interacting with Atg13","volume":"5","author":"Hosokawa","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2018.07.004_bib0400","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1091\/mbc.e08-12-1248","article-title":"Nutrient-dependent mTORC1 association with the ULK1\u2013Atg13\u2013FIP200 complex required for autophagy","volume":"20","author":"Hosokawa","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.phrs.2018.07.004_bib0405","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ncb2708","article-title":"mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6","volume":"15","author":"Nazio","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0410","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ncb2757","article-title":"ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase","volume":"15","author":"Russell","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0415","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome\u2010to\u2010nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2018.07.004_bib0420","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/cbt.26206","article-title":"Omega-3 polyunsaturated fatty acid promotes the inhibition of glycolytic enzymes and mTOR signaling by regulating the tumor suppressor LKB1","volume":"14","author":"Andrade-Vieira","year":"2013","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phrs.2018.07.004_bib0425","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2016.01.012","article-title":"PI3K\/Akt\/mTOR and Ras\/Raf\/ MEK\/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives","volume":"109","author":"Asati","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0430","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2007.04.002","article-title":"mTOR Complex1\u2013S6K1 signaling: at the crossroads of obesity, diabetes and cancer","volume":"13","author":"Dann","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0435","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1","volume":"71","author":"Sahra","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0440","first-page":"9","article-title":"Non alcoholic fatty liver disease and metabolic syndrome","volume":"13","author":"Paschos","year":"2009","journal-title":"Hippokratia"},{"key":"10.1016\/j.phrs.2018.07.004_bib0445","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2018.07.004_bib0450","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2010.11.003","article-title":"Autophagy and misfolded proteins in neurodegeneration","volume":"238","author":"Metcalf","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0455","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/2319-4170.110365","article-title":"Mammalian target of rapamycin (mTOR) pathways in neurological diseases","volume":"36","author":"Wong","year":"2013","journal-title":"Biomed. J."},{"key":"10.1016\/j.phrs.2018.07.004_bib0460","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/brain\/awm318","article-title":"The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson\u2019s disease","volume":"131","author":"Pan","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2018.07.004_bib0465","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2011.200","article-title":"Control of autophagy as a therapy for neurodegenerative disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0470","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tips.2014.09.002","article-title":"Targeting autophagy in neurodegenerative diseases","volume":"35","author":"Vidal","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0475","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrn3961","article-title":"Compromised autophagy and neurodegenerative diseases","volume":"16","author":"Menzies","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0480","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0485","doi-asserted-by":"crossref","first-page":"12977","DOI":"10.1523\/JNEUROSCI.4209-06.2006","article-title":"Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons","volume":"26","author":"Parsons","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0490","doi-asserted-by":"crossref","first-page":"35215","DOI":"10.1074\/jbc.M004446200","article-title":"Inhibition of neuronal apoptosis by docosahexaenoic acid (22: 6n-3) role of phosphatidylserine in antiapoptotic effect","volume":"275","author":"Kim","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0495","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1097-2765(03)00114-X","article-title":"G\u03b2L, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and Mtor","volume":"11","author":"Kim","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phrs.2018.07.004_bib0500","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0505","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","article-title":"Tau aggregation and its interplay with amyloid-\u03b2","volume":"129","author":"Nisbet","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0510","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1567205011310040008","article-title":"Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-\u03b2 pathology in a mouse model of Alzheimer\u2019s disease","volume":"10","author":"Li","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0515","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.2337\/db11-1735","article-title":"Altered APP processing in insulin-resistant conditions is mediated by autophagosome accumulation via the inhibition of mammalian target of rapamycin pathway","volume":"61","author":"Son","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2018.07.004_bib0520","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1471-4159.2005.03187.x","article-title":"mTOR\/p70S6k signalling alteration by A\u03b2 exposure as well as in APP\u2010PS1 transgenic models and in patients with Alzheimer\u2019s disease","volume":"94","author":"Lafay\u2010Chebassier","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0525","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","article-title":"Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer\u2019s disease","volume":"28","author":"Boland","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0530","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2147\/NDT.S75717","article-title":"Activation of mTOR: a culprit of Alzheimer\u2019s disease?","volume":"11","author":"Cai","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.phrs.2018.07.004_bib0535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.07.004_bib0540","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0545","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2017.01.004","article-title":"Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer\u2019s disease","volume":"149","author":"Franco","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0550","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer\u2019s disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.phrs.2018.07.004_bib0555","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cytogfr.2017.04.005","article-title":"Control of B lymphocyte development and functions by the mTOR signaling pathways","volume":"35","author":"Iwata","year":"2017","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.phrs.2018.07.004_bib0560","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bbadis.2015.11.010","article-title":"Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer\u2019s disease","volume":"1862","author":"Galvan","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) \u2013 Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012845","article-title":"Dysregulation of the mTOR pathway mediates impairment of synaptic plasticity in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Ma","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.07.004_bib0570","series-title":"Encyclopedia of Cell Biology","first-page":"128","article-title":"The PI3K\/Akt\/mTOR pathway","author":"Evangelisti","year":"2016"},{"key":"10.1016\/j.phrs.2018.07.004_bib0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.07.004_bib0580","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jnc.12080","article-title":"Over\u2010expression of heat shock factor 1 phenocopies the effect of chronic inhibition of TOR by rapamycin and is sufficient to ameliorate Alzheimer\u2019s\u2010like deficits in mice modeling the disease","volume":"124","author":"Pierce","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0585","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbamcr.2015.03.003","article-title":"mTor mediates tau localization and secretion: implication for Alzheimer\u2019s disease","volume":"1853","author":"Tang","year":"2015","journal-title":"Biochim. Biophysic. Acta (BBA)-Mol. Cell Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0590","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/acel.12057","article-title":"mTOR regulates tau phosphorylation and degradation: implications for Alzheimer\u2019s disease and other tauopathies","volume":"12","author":"Caccamo","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.phrs.2018.07.004_bib0595","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neuint.2013.01.014","article-title":"Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase","volume":"62","author":"Liu","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.phrs.2018.07.004_bib0600","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1074\/jbc.M110.100420","article-title":"Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-\u03b2, and tau effects on cognitive impairments","volume":"285","author":"Caccamo","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0605","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2005-06-2448","article-title":"A prospective study of the natural history of transient leukemia (TL) in neonates with down syndrome (DS): Children9s Oncology Group (COG) study POG-9481","volume":"107","author":"Massey","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2018.07.004_bib0610","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1601-183X.2003.00026.x","article-title":"Down\u2019s syndrome: a genetic disorder in biobehavioral perspective","volume":"2","author":"Nadel","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.phrs.2018.07.004_bib0615","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2010.11.166","article-title":"Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in down\u2019s syndrome","volume":"102","author":"Infantino","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.phrs.2018.07.004_bib0620","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.yexcr.2012.09.017","article-title":"Modeling neurogenesis impairment in down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells","volume":"319","author":"Lu","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0625","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/378776a0","article-title":"Apoptosis and increased generation of reactive oxygen species in Down\u2019s syndrome neurons in vitro","volume":"378","author":"Busciglio","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2018.07.004_bib0630","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.bbadis.2013.04.013","article-title":"Impairment of proteostasis network in down syndrome prior to the development of Alzheimer\u2019s disease neuropathology: redox proteomics analysis of human brain","volume":"1832","author":"Di Domenico","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0635","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: at the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0640","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.freeradbiomed.2017.08.009","article-title":"mTOR in Down syndrome: role in A\u00df and tau neuropathology and transition to Alzheimer disease-like dementia","volume":"114","author":"Di Domenico","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0645","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in Parkinson\u2019s disease","volume":"246","author":"Burke","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0650","doi-asserted-by":"crossref","first-page":"e1209","DOI":"10.1038\/cddis.2014.175","article-title":"Metformin lowers Ser-129 phosphorylated \u03b1-synuclein levels via mTOR-dependent protein phosphatase 2A activation","volume":"5","author":"P\u00e9rez-Revuelta","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0655","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1523\/JNEUROSCI.3944-09.2010","article-title":"Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson\u2019s disease","volume":"30","author":"Malagelada","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0660","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1016\/j.febslet.2015.10.002","article-title":"Dissecting the role of Engrailed in adult dopaminergic neurons \u2013 insights into Parkinson disease pathogenesis","volume":"589","author":"Rekaik","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2018.07.004_bib0665","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/WNR.0000000000000871","article-title":"Triggering of inflammasome by impaired autophagy in response to acute experimental Parkinson\u2019s disease: involvement of the PI3K\/Akt\/mTOR pathway","volume":"28","author":"Giacoppo","year":"2017","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2018.07.004_bib0670","first-page":"8716016","article-title":"Comparative mRNA expression of eEF1A isoforms and a PI3K\/Akt\/mTOR pathway in a cellular model of Parkinson\u2019s disease","volume":"2016","author":"Khwanraj","year":"2016","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-016-8417-7","article-title":"mTOR signaling in Parkinson\u2019s disease","volume":"19","author":"Lan","year":"2017","journal-title":"Neuromol. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0680","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2007.12.034","article-title":"Caffeine activates the PI3K\/Akt pathway and prevents apoptotic cell death in a Parkinson\u2019s disease model of SH-SY5Y cells","volume":"432","author":"Nakaso","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2018.07.004_bib0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2014.07.001","article-title":"G2019S LRRK2 mutant fibroblasts from Parkinson\u2019s disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy","volume":"324","author":"Yakhine-Diop","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.phrs.2018.07.004_bib0690","article-title":"Roles of PI3K\/AKT\/GSK3\/mTOR pathway in cell signaling of mental illnesses","volume":"2012","author":"Kitagishi","year":"2012","journal-title":"Depress. Res. Treat."},{"key":"10.1016\/j.phrs.2018.07.004_bib0695","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2018.07.004_bib0700","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/toxsci\/kfu211","article-title":"Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K1 and 4E-BP1\/eIF4E pathways, leading to neuronal apoptosis","volume":"143","author":"Zhou","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0705","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jmb.2012.06.034","article-title":"DJ-1 protects dopaminergic neurons against rotenone-induced apoptosis by enhancing ERK-dependent mitophagy","volume":"423","author":"Gao","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0710","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neuroscience.2014.11.004","article-title":"Rotenone impairs autophagic flux and lysosomal functions in Parkinson\u2019s disease","volume":"284","author":"Wu","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2018.07.004_bib0715","series-title":"Molecules to Medicine with mTOR","first-page":"85","article-title":"Chapter 6 \u2013 the mTOR signaling pathway in neurodegenerative diseases A2 - Maiese, Kenneth","author":"Francois","year":"2016"},{"key":"10.1016\/j.phrs.2018.07.004_bib0720","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2017.01.063","article-title":"Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson\u2019s disease","volume":"642","author":"Kang","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2018.07.004_bib0725","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.cellsig.2014.04.009","article-title":"Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson\u2019s disease","volume":"26","author":"Xu","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2018.07.004_bib0730","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.freeradbiomed.2015.02.030","article-title":"Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease","volume":"84","author":"Zhang","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0735","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phrs.2018.07.004_bib0740","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0745","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.neurobiolaging.2011.06.002","article-title":"Dietary restriction but not rapamycin extends disease onset and survival of the H46R\/H48Q mouse model of ALS","volume":"33","author":"Bhattacharya","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2018.07.004_bib0750","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/auto.7.4.14541","article-title":"Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Zhang","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2018.07.004_bib0755","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4161\/auto.23958","article-title":"Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy","volume":"9","author":"Ching","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2018.07.004_bib0760","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4161\/auto.27710","article-title":"MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Zhang","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2018.07.004_bib0765","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biochi.2017.07.011","article-title":"Structural studies of amyloid-\u03b2 peptides: unlocking the mechanism of aggregation and the associated toxicity","volume":"140","author":"Aleksis","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.phrs.2018.07.004_bib0770","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/07853898909149187","article-title":"The deposition of amyloid proteins in the aging mammalian brain: implications for Alzheimer\u2019s disease","volume":"21","author":"Selkoe","year":"1989","journal-title":"Ann. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0775","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12929-016-0241-8","article-title":"Novel insights into the effect of vitamin B 12 and omega-3 fatty acids on brain function","volume":"23","author":"Rathod","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0780","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaac.2011.06.008","article-title":"Omega-3 fatty acid supplementation for the treatment of children with attention-deficit\/hyperactivity disorder symptomatology: systematic review and meta-analysis","volume":"50","author":"Bloch","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.phrs.2018.07.004_bib0785","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3233\/JAD-130131","article-title":"Omega-3 fatty acids enhance phagocytosis of Alzheimer\u2019s disease-related amyloid-\u03b242 by human microglia and decrease inflammatory markers","volume":"35","author":"Hjorth","year":"2013","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0790","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jff.2017.01.010","article-title":"\u03c9-3 polyunsaturated fatty acid supplementation ameliorates lipopolysaccharide-induced behavioral deficits and modulates neurotrophic factors in rats: focus on tPA\/PAI-1 system and BDNF-TrkB signaling","volume":"30","author":"Dang","year":"2017","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.phrs.2018.07.004_bib0795","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jnutbio.2017.07.012","article-title":"EPA and DHA, but not ALA, have antidepressant effects with 17\u03b2-estradiol injection via regulation of a neurobiological system in ovariectomized rats","volume":"49","author":"Choi","year":"2017","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0800","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3233\/JAD-132042","article-title":"Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer\u2019s disease: the OmegAD study","volume":"42","author":"Freund-Levi","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0805","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3233\/JAD-150102","article-title":"Plasma fatty acid profiles in relation to cognition and gender in Alzheimer\u2019s disease patients during oral omega-3 fatty acid supplementation: the omegad study","volume":"48","author":"Eriksdotter","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0810","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.plefa.2007.10.019","article-title":"Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies","volume":"77","author":"Calon","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.phrs.2018.07.004_bib0815","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2006-9S311","article-title":"Synaptic remodeling during aging and in Alzheimer\u2019s disease","volume":"9","author":"Masliah","year":"2006","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0820","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","article-title":"A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model","volume":"25","author":"Lim","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0825","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nbd.2006.04.013","article-title":"Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP\/PS1 transgenic mice","volume":"23","author":"Oksman","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib0830","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","article-title":"Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-\u03b2 and tau pathology via a mechanism involving presenilin 1 levels","volume":"27","author":"Green","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0835","doi-asserted-by":"crossref","first-page":"RC118","DOI":"10.1523\/JNEUROSCI.21-01-j0001.2001","article-title":"Amyloid-\u03b2 peptides are cytotoxic to oligodendrocytes","volume":"21","author":"Xu","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0840","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1083\/jcb.200110119","article-title":"Selective cytotoxicity of intracellular amyloid \u03b2 peptide1\u201342 through p53 and Bax in cultured primary human neurons","volume":"156","author":"Zhang","year":"2002","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0845","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00381-015-2990-1","article-title":"The investigation of the prenatal and postnatal alcohol exposure-induced neurodegeneration in rat brain: protection by betaine and\/or omega-3","volume":"32","author":"Kusat Ol","year":"2016","journal-title":"Child\u2019s Nervous Syst."},{"key":"10.1016\/j.phrs.2018.07.004_bib0850","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/cercor\/bhq244","article-title":"The acute impact of ethanol on cognitive performance in rhesus macaques","volume":"21","author":"Jedema","year":"2011","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.phrs.2018.07.004_bib0855","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/0883073811428377","article-title":"Fetal alcohol spectrum disorders-implications for child neurology, part 2: diagnosis and management","volume":"27","author":"Paintner","year":"2012","journal-title":"J. Childern Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0860","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.287.5455.1056","article-title":"Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome","volume":"287","author":"Ikonomidou","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.phrs.2018.07.004_bib0865","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.22419","article-title":"Neuronal cell death in neonatal hypoxia-ischemia","volume":"69","author":"Northington","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0870","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ntt.2005.11.001","article-title":"Neocortical neurodegeneration in young adult Wistar rats prenatally exposed to ethanol","volume":"28","author":"Fakoya","year":"2006","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0875","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/ajcn\/77.4.803","article-title":"Cognitive decline and fatty acid composition of erythrocyte membranes\u2014The EVA Study","volume":"77","author":"Heude","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib0880","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archneur.62.12.noc50161","article-title":"Fish consumption and cognitive decline with age in a large community study","volume":"62","author":"Morris","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0885","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcn\/85.4.1142","article-title":"Fish consumption, n\u2212 3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen elderly study","volume":"85","author":"van Gelder","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib0890","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1212\/01.wnl.0000324268.45138.86","article-title":"Effect of fish oil on cognitive performance in older subjects A randomized, controlled trial","volume":"71","author":"van de Rest","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2018.07.004_bib0895","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1007\/BF02562338","article-title":"Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases","volume":"34","author":"Terano","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.phrs.2018.07.004_bib0900","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neures.2006.06.010","article-title":"Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","volume":"56","author":"Kotani","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0905","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"\u03c9-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD Study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0910","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.plefa.2012.05.006","article-title":"Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria","volume":"88","author":"Eckert","year":"2013","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.phrs.2018.07.004_bib0915","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biocel.2011.10.007","article-title":"Omega-3 fatty acids enhance mitochondrial superoxide dismutase activity in rat organs during post-natal development","volume":"44","author":"Garrel","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0920","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/jcm5020015","article-title":"Omega-3 fatty acids and cancer cell cytotoxicity: implications for multi-targeted cancer therapy","volume":"5","author":"D\u2019Eliseo","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib0925","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.2009.06403.x","article-title":"Pathogenesis of familial Parkinson\u2019s disease: new insights based on monogenic forms of Parkinson\u2019s disease","volume":"111","author":"Hatano","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0930","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","article-title":"Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia","volume":"580","author":"Obeid","year":"2006","journal-title":"FEBS Lett."},{"issue":"2010","key":"10.1016\/j.phrs.2018.07.004_bib0935","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.plefa.2010.02.025","article-title":"Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid","volume":"82","author":"Kim","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.phrs.2018.07.004_bib0940","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0968-0004(01)01958-2","article-title":"Ten years of protein kinase B signalling: a hard Akt to follow","volume":"26","author":"Brazil","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0945","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1471-4159.2002.01015.x","article-title":"Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway","volume":"82","author":"Akbar","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2018.07.004_bib0950","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1073\/pnas.0502903102","article-title":"Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival","volume":"102","author":"Akbar","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.07.004_bib0955","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12035-011-8174-4","article-title":"Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer\u2019s disease cellular models","volume":"43","author":"Stark","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2018.07.004_bib0960","article-title":"Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase-and PPAR\u03b3-mediated mechanisms in Alzheimer\u2019s disease models","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.07.004_bib0965","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1007\/s11064-010-0351-8","article-title":"NPD1 induction of retinal pigment epithelial cell survival involves PI3K\/Akt phosphorylation signaling","volume":"35","author":"Halapin","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0970","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.exer.2010.03.002","article-title":"PI3K\/Akt and mTOR\/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis","volume":"90","author":"Faghiri","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib0975","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"\u03b2-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib0980","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jnutbio.2008.07.003","article-title":"The influence of orally administered docosahexaenoic acid on cognitive ability in aged mice","volume":"20","author":"Jiang","year":"2009","journal-title":"J. Nutr. Biochem."},{"issue":"2001","key":"10.1016\/j.phrs.2018.07.004_bib0985","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1073\/pnas.051626998","article-title":"Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors","volume":"98","author":"Calza","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2011","key":"10.1016\/j.phrs.2018.07.004_bib0990","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1073\/pnas.1007640108","article-title":"Reversible modulation of neuronal plasticity by VEGF","volume":"108","author":"Licht","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.07.004_bib0995","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2008.398","article-title":"Silibinin inhibits hypoxia-inducible factor-1\u03b1 and mTOR\/p70S6K\/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy","volume":"28","author":"Garcia-Maceira","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.phrs.2018.07.004_bib1000","first-page":"239","article-title":"\u03c93-polyunsaturated fatty acids induce cell death through apoptosis and autophagy in glioblastoma cells: in vitro and in vivo","volume":"39","author":"Kim","year":"2018","journal-title":"Oncol. Rep."},{"issue":"2015","key":"10.1016\/j.phrs.2018.07.004_bib1005","first-page":"239764","article-title":"Docosahexaenoic acid induces cell death in human non-small cell lung cancer cells by repressing mTOR via AMPK activation and PI3K\/Akt inhibition","volume":"2015","author":"Kim","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.phrs.2018.07.004_bib1010","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.3892\/or.2016.4720","article-title":"n-3 polyunsaturated fatty acids abrogate mTORC1\/2 signaling and inhibit adrenocortical carcinoma growth in vitro and in vivo","volume":"35","author":"Liu","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.phrs.2018.07.004_bib1015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/08923973.2016.1208221","article-title":"n-3 fatty acids modulate the mRNA expression of the Nlrp3 inflammasome and Mtor in the liver of rats fed with high-fat or high-fat\/fructose diets","volume":"38","author":"Garay-Lugo","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.phrs.2018.07.004_bib1020","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1177\/1947601911407325","article-title":"PTEN tumor suppressor network in PI3K-Akt pathway control","volume":"1","author":"Georgescu","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.phrs.2018.07.004_bib1025","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1172\/JCI87388","article-title":"\u03c9-3 polyunsaturated fatty acids ameliorate type 1 diabetes and autoimmunity","volume":"127","author":"Bi","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2018.07.004_bib1030","doi-asserted-by":"crossref","first-page":"568671","DOI":"10.1155\/2013\/568671","article-title":"The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53","volume":"2013","author":"Shin","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.phrs.2018.07.004_bib1035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3945\/ajcn.110.005611","article-title":"Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial","volume":"93","author":"Smith","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2018.07.004_bib1040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1179\/1476830512Y.0000000026","article-title":"Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: a comparison of individuals with and without cognitive impairment and Alzheimer\u2019s disease","volume":"15","author":"Phillips","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.phrs.2018.07.004_bib1045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.07.021","article-title":"Synergistic anti-tumor effect of 17AAG with the PI3K\/mTOR inhibitor NVP-BEZ235 on human melanoma","volume":"406","author":"Calero","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2018.07.004_bib1050","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.wneu.2017.08.122","article-title":"Presurgical administration of mTOR inhibitors in patients with large subependymal giant cell astrocytoma associated with tuberous sclerosis complex","volume":"107","author":"Jiang","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.phrs.2018.07.004_bib1055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.fct.2014.03.017","article-title":"The effects of bioactive compounds from plant foods on mitochondrial function: a focus on apoptotic mechanisms","volume":"68","author":"Forbes-Hern\u00e1ndez","year":"2014","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phrs.2018.07.004_bib1060","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.18632\/oncotarget.2209","article-title":"Deregulation of the EGFR\/PI3K\/PTEN\/Akt\/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention","volume":"5","author":"Davis","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2018.07.004_bib1065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/acn3.419","article-title":"Immune and myodegenerative pathomechanisms in inclusion body myositis","volume":"4","author":"Keller","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib1070","first-page":"177","article-title":"Oxidative stress in the aging process: fundamental aspects and new insights","volume":"Vol. 2","author":"Gil del Valle","year":"2015"},{"key":"10.1016\/j.phrs.2018.07.004_bib1075","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/961438","article-title":"The effects of omega-3 fatty acid supplementation on dexamethasone-induced muscle atrophy","volume":"2014","author":"Fappi","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.phrs.2018.07.004_bib1080","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3390\/ijms18102081","article-title":"High endogenous accumulation of \u03c9-3 polyunsaturated fatty acids protect against ischemia-reperfusion renal injury through AMPK-mediated autophagy in fat-1 mice","volume":"18","author":"Gwon","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib1085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.phrs.2017.02.005","article-title":"Guidelines for preparing color figures for everyone including the colorblind","volume":"119","author":"Roskoski","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib1090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol. Cell"},{"issue":"2015","key":"10.1016\/j.phrs.2018.07.004_bib1095","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.2174\/1568026615666150610125856","article-title":"Age-related neurodegeneration prevention through mTOR inhibition: potential mechanisms and remaining questions","volume":"15","author":"Jahrling","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.phrs.2018.07.004_bib1100","doi-asserted-by":"crossref","DOI":"10.4103\/2319-4170.110365","article-title":"Mammalian target of rapamycin (mTOR) pathways in neurological diseases","volume":"36","author":"Wong","year":"2013","journal-title":"Biomed. J."},{"key":"10.1016\/j.phrs.2018.07.004_bib1105","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4161\/oxim.3.6.14787","article-title":"Mammalian target of rapamycin: hitting the Bull\u2019s-Eye for neurological disorders","volume":"3","author":"Chong","year":"2010","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"2017","key":"10.1016\/j.phrs.2018.07.004_bib1110","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin\u2013a future therapy for neurodegenerative diseases","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib1115","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbrc.2017.01.157","article-title":"Chronic metformin treatment facilitates seizure termination","volume":"484","author":"Yang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2018.07.004_bib1120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.pnpbp.2007.11.013","article-title":"Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine","volume":"32","author":"Chen","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.phrs.2018.07.004_bib1125","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11481-012-9431-7","article-title":"Curcumin ameliorates the neurodegenerative pathology in A53T \u03b1-synuclein cell model of Parkinson\u2019s disease through the downregulation of mTOR\/p70S6K signaling and the recovery of macroautophagy","volume":"8","author":"Jiang","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2013","key":"10.1016\/j.phrs.2018.07.004_bib1130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2013.05.029","article-title":"Role of the mTOR signaling pathway in epilepsy","volume":"332","author":"Meng","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.phrs.2018.07.004_bib1135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hermed.2015.01.002","article-title":"Neuroprotective therapeutics from botanicals and phytochemicals against Huntington\u2019s disease and related neurodegenerative disorders","volume":"5","author":"Dey","year":"2015","journal-title":"J. Herbal Med."},{"key":"10.1016\/j.phrs.2018.07.004_bib1140","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroscience.2016.07.038","article-title":"Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer\u2019s disease","volume":"333","author":"Wu","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2018.07.004_bib1145","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-150470","article-title":"Hippocampal lipid homeostasis in APP\/PS1 mice is modulated by a complex interplay between dietary DHA and estrogens: relevance for Alzheimer\u2019s disease","volume":"49","author":"Diaz","year":"2016","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib1150","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.nbd.2015.09.002","article-title":"Dietary DHA supplementation in an APP\/PS1 transgenic rat model of AD reduces behavioral and a\u03b2 pathology and modulates A\u03b2 oligomerization","volume":"82","author":"Teng","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"2017","key":"10.1016\/j.phrs.2018.07.004_bib1155","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1096\/fj.201700290R","article-title":"Omega-3 fatty acids increase the unfolded protein response and improve amyloid-\u03b2 phagocytosis by macrophages of patients with mild cognitive impairment","volume":"31","author":"Olivera-Perez","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2018.07.004_bib1160","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.physbeh.2015.08.025","article-title":"Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans","volume":"151","author":"Shashikumar","year":"2015","journal-title":"Physiol. Behav."},{"issue":"2018","key":"10.1016\/j.phrs.2018.07.004_bib1165","first-page":"168","article-title":"Omega-3 fatty acid supplementation may prevent loss of gray matter thickness in the left parieto-occipital cortex in first episode schizophrenia: a secondary outcome analysis of the OFFER randomized controlled study","volume":"195","author":"Pawe\u0142czyk","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib1170","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ana.25059","article-title":"Docosahexaenoic acid (DHA) is a beneficial replacement treatment for Spinocerebellar Ataxia 38 (SCA38)","volume":"82","author":"Manes","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.phrs.2018.07.004_bib1175","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/nu9070681","article-title":"Natural docosahexaenoic acid in the triglyceride form attenuates in vitro microglial activation and ameliorates autoimmune encephalomyelitis in mice","volume":"9","author":"Mancera","year":"2017","journal-title":"Nutrients"},{"issue":"2017","key":"10.1016\/j.phrs.2018.07.004_bib1180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.prostaglandins.2017.06.001","article-title":"A diet rich in omega-3 fatty acids enhances expression of soluble epoxide hydrolase in murine brain","volume":"133","author":"Ostermann","year":"2017","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.phrs.2018.07.004_bib1185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-016-0194-x","article-title":"The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer\u2019s disease","volume":"8","author":"Yassine","year":"2016","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.phrs.2018.07.004_bib1190","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/mds.26308","article-title":"Ethyl\u2010eicosapentaenoic acid treatment in Huntington\u2019s disease: a placebo-controlled clinical trial","volume":"30","author":"Ferreira","year":"2015","journal-title":"Mov. Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib1195","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1194\/jlr.P055418","article-title":"Effects of n-3 FA supplementation on the release of proresolving lipid mediators by blood mononuclear cells: the OmegAD study","volume":"56","author":"Wang","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2018.07.004_bib1200","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-141305","article-title":"Tolerability and safety of sSouvenaid in patients with mild Alzheimer\u2019s disease: results of multi-center, 24-week, open-label extension study","volume":"44","author":"Rikkert","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib1205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000369811","article-title":"Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept study","volume":"15","author":"Pardini","year":"2015","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.phrs.2018.07.004_bib1210","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2017.01.026","article-title":"Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis \u2013 results of the randomized controlled Vienna omega-3 study","volume":"188","author":"Smesny","year":"2017","journal-title":"Schizophr. Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818305310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661818305310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T04:58:54Z","timestamp":1717304334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661818305310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":242,"alternative-id":["S1043661818305310"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.07.004","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mTORs by omega-3 fatty acids: A possible novel therapeutic strategy for neurodegeneration?","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}